Skip to main content
Caplight Logo









Pluristyx

Pluristyx

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://pluristyx.com/

Last Round

Series A

Jul 13, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Pluristyx is a biotechnology company that provides induced pluripotent stem cell (iPSC) products, contract development, and manufacturing services to accelerate the development of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

induced pluripotent stem cellsiPSCscell therapygene editingCDMO servicesoff-the-shelf cell therapyallogeneic cell therapyimmune evasion technologyimmune cloakingcell therapy safety switchkill switch technologyregenerative medicinecell line developmentGMP cell linesCMC supportcellular reprogrammingorganoid productsAI-augmented cell manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pluristyx Comparables

Compare Pluristyx with similar companies based on industry and business-model similarity.

Pluristyx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellistic
78%
Ncardia
77%
bit.bio
77%

Pluristyx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 13, 2026
GrantNov 17, 2025
Convertible DebtJul 28, 2025
Early FundingDec 21, 2023

Key People

Founding team and executive leadership

Jason Carstens

Chief Operating Officer And Co-Founder, Chairman Of The Board

Founding Team

Benjamin Fryer

Co-Founder And CEO

Founding Team

Priya Baraniak

Chief Commercial And Development Officer, Director, Board Of Directors

Executive Team

Pluristyx Investors

Notable investors and investment history

Pluristyx investors
InvestorRounds
JDRFGrant
BroadOak Capital PartnersConvertible Debt, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 41% MoM.

  • Jul 13, 2026

    Raised $10M in Series A funding.

Pluristyx Filings

Explore SEC and related filing metadata, where available.

Pluristyx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pluristyx's valuation, stock price, and market status.

Is Pluristyx a public or private company?

Pluristyx is a private company.

What is the current stock price of Pluristyx?

Pluristyx is a private company with no public stock price. No recent secondary market data is available.

How much is Pluristyx worth (valuation)?

Valuation information for Pluristyx is not publicly available.

Can I buy Pluristyx stock?

Pluristyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pluristyx's last funding round?

Pluristyx's most recent funding round was Grant on November 17, 2025.

Who are the main investors in Pluristyx?

Key investors in Pluristyx include BroadOak Capital Partners.

Will Pluristyx IPO soon?

No public IPO plans have been announced for Pluristyx.

How can I track Pluristyx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pluristyx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range16
Year Founded2018
Last FundingJul 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?